Preclinical Efficacy of Dual mTORC1/2 Inhibitor AZD8055 in Renal Cell Carcinoma Harboring a TFE3 Gene Fusion

BMC Cancer - United Kingdom
doi 10.1186/s12885-019-6096-0
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Fusion of Splicing Factor Genes PSF and NonO (P54nrb) to the TFE3 Gene in Papillary Renal Cell Carcinoma

Oncogene
Cancer ResearchGeneticsMolecular Biology
1997English

Potentiation of the Anticancer Effects of Everolimus Using a Dual mTORC1/2 Inhibitor in Hepatocellular Carcinoma Cells

Oncotarget
Oncology
2016English

Renal Cell Carcinoma Associated With Xp11.2 Translocation/Tfe3 Gene Fusions: Clinical Features, Treatments and Prognosis

PLoS ONE
Multidisciplinary
2016English

The Novel mTORC1/2 Dual Inhibitor INK128 Enhances Radiosensitivity of Breast Cancer Cell Line McF-7

International Journal of Oncology
Cancer ResearchOncology
2016English

Rho GDP Dissociation Inhibitor‑β in Renal Cell Carcinoma

Oncology Letters
Cancer ResearchOncology
2017English

Gene Expression of Erythropoietin in Renal Cell Carcinoma.

Internal Medicine
Internal MedicineMedicine
1999English

PUB047 Efficacy of EGFR-TKI for Lung Adenosquamous Cell Carcinoma Harboring EGFR Mutation

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2017English

Identification of a Suitable qPCR Reference Gene in Metastatic Clear Cell Renal Cell Carcinoma

Tumor Biology
MedicineCancer Research
2014English

Gene Amplification and Overexpression of HER2 in Renal Cell Carcinoma

BJU International
Urology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy